Reduced Intensity BMT for Immune Dysregulatory and Bone Marrow Failure Syndromes Using Post-Transplant Cyclophosphamide

Conditions:   Primary Immune Deficiency Disorder;   Immune Deficiency Disease;   Bone Marrow Failure Interventions:   Drug: Alemtuzumab;   Drug: Fludarabine;   Drug: Melphalan;   Radiation: Low Dose Total Body Irradiation;   Drug: Cyclophosphamide;   Drug: Tacrolimus;   Drug: Mycophenolate Mofetil Sponsor:   Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials